Homocysteine Level and Risk of Hemorrhage in Brain Arteriovenous Malformations
- PMID: 33859768
- PMCID: PMC8026282
- DOI: 10.1155/2021/8862299
Homocysteine Level and Risk of Hemorrhage in Brain Arteriovenous Malformations
Abstract
Objective: We aimed to investigate the risk factors associated with hemorrhage and clarify the relation of homocysteine (Hcy) with brain arteriovenous malformations (bAVMs).
Method: We retrospectively reviewed bAVM patients from Beijing Tiantan Hospital between January 2019 and December 2019. Clinical and laboratory variables were analyzed in enrolled patients with bAVMs. Potential predictors associated with hemorrhage were evaluated by logistic regression analysis.
Results: A total of 143 bAVM patients were identified in the study, including 69 unruptured and 74 ruptured cases. Patients with hemorrhage were less likely to have hyperhomocysteinemia (P = 0.023). Logistic regression analysis showed that increased maximum diameter of bAVM lesions (odds ratio (OR) 0.634, 95% confidence intervals (CI) 0.479-0.839; P = 0.001) and serum Hcy level (OR 0.956, 95% CI 0.920-0.993; P = 0.021) were associated with lower risk of hemorrhage in bAVMs.
Conclusion: The present study provided evidence regarding the association between serum Hcy and hemorrhage in patients with bAVMs. Higher Hcy level was correlated with a lower risk of rupture. Detection of factors for subsequent hemorrhage is necessary to develop therapeutic strategies for bAVMs preferably.
Copyright © 2021 Chaofan Zeng et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures



Similar articles
-
Prognostic Significance of Homocysteine Level on Neurological Outcome in Brain Arteriovenous Malformations.Dis Markers. 2020 Nov 30;2020:6661475. doi: 10.1155/2020/6661475. eCollection 2020. Dis Markers. 2020. PMID: 33312268 Free PMC article.
-
Risk factors for delayed postoperative hemorrhage in patients with brain arteriovenous malformations: an analysis of the nationwide multicenter prospective registry MATCH study.J Neurosurg. 2024 Mar 8;141(2):316-322. doi: 10.3171/2023.12.JNS231539. Print 2024 Aug 1. J Neurosurg. 2024. PMID: 38457809
-
Long-term outcome of 106 consecutive pediatric ruptured brain arteriovenous malformations after combined treatment.Stroke. 2014 Jun;45(6):1664-71. doi: 10.1161/STROKEAHA.113.004292. Epub 2014 May 1. Stroke. 2014. PMID: 24788975 Clinical Trial.
-
Pathogenesis and radiobiology of brain arteriovenous malformations: implications for risk stratification in natural history and posttreatment course.Neurosurg Focus. 2009 May;26(5):E9. doi: 10.3171/2009.2.FOCUS0926. Neurosurg Focus. 2009. PMID: 19409010 Review.
-
Machine Learning Models for Brain Arteriovenous Malformations Presenting with Hemorrhage Based on Clinical and Angioarchitectural Characteristics.Acad Radiol. 2024 Apr;31(4):1583-1593. doi: 10.1016/j.acra.2023.08.023. Epub 2023 Sep 30. Acad Radiol. 2024. PMID: 37783607
Cited by
-
Association Between Folate Metabolism Risk, Collateral Circulation, and Hemorrhagic Risk in Moyamoya Disease.Transl Stroke Res. 2025 Oct;16(5):1536-1549. doi: 10.1007/s12975-024-01324-y. Epub 2025 Jan 8. Transl Stroke Res. 2025. PMID: 39775251
References
-
- Holmes M., Newcombe P., Hubacek J., et al. Effect modification by population dietary folate on the association between _MTHFR_ genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. The Lancet. 2011;378(9791):584–594. doi: 10.1016/s0140-6736(11)60872-6. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical